The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia

被引：0

作者：

Morabito, Fortunato ^{[1
]}

Tripepi, Giovanni ^{[2
]}

Mauro, Francesca Romana ^{[3
]}

Laurenti, Luca ^{[4
]}

Reda, Gianluigi ^{[5
,6
]}

Moia, Riccardo ^{[7
]}

Condoluci, Adalgisa ^{[8
,9
]}

Vincelli, Iolanda ^{[10
]}

Chiarenza, Annalisa ^{[11
]}

Vigna, Ernesto ^{[12
]}

Martino, Enrica Antonia ^{[12
]}

Bruzzese, Antonella

Mezzatesta, Sabrina ^{[2
]}

Laureana, Roberta ^{[13
]}

Cutrona, Giovanna ^{[14
]}

Di Raimondo, Francesco

Fronza, Gilberto ^{[15
]}

Zucchetto, Antonella ^{[16
]}

Bomben, Riccardo ^{[16
]}

Rossi, Francesca Maria ^{[16
]}

Olivieri, Jacopo ^{[17
]}

Zaja, Francesco ^{[18
]}

Rossi, Davide ^{[8
,9
]}

Gaidano, Gianluca ^{[7
]}

Del Principe, Maria Ilaria ^{[13
]}

Ilariucci, Fiorella ^{[19
]}

Del Poeta, Giovanni ^{[13
]}

Ferrarini, Manlio ^{[14
]}

Neri, Antonino ^{[20
]}

Gattei, Valter ^{[16
]}

Gentile, Massimo ^{[12
,21
]}

机构：

[1] AO ASP Cosenza, Biotechnol Res Unit, Aprigliano, I-87100 Cosenza, Italy

[2] CNR, Ist Fisiol Clin CNR, Reggio Di Calabria, Italy

[3] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy

[4] Catholic Univ Hosp A Gemelli Rome, Dept Hematol, Rome, Italy

[5] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy

[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol CTMO, Milan, Italy

[7] Univ Piemonte Orientale, Dept Translat Med, Div Haematol, Novara, Italy

[8] Oncol Inst Southern Switzerland, Bellinzona, Switzerland

[9] Inst Oncol Res, Bellinzona, Switzerland

[10] Hematol Unit Reggio Calabria, Reggio Di Calabria, Italy

[11] Univ Catania, Osped Ferrarotto, Div Ematol, Catania, Italy

[12] AO Cosenza, Dept Oncohematol, Hematol Unit, Cosenza, Italy

[13] Univ Roma Tor Vergata, Dipartimento Biomed & Prevenz, Ematol, Rome, Italy

[14] Osped Policlin San Martino IRCCS, UO Mol Pathol, Genoa, Italy

[15] IRCCS Osped Policlin San Martino, Mutagenesis & Canc Prevent Unit, Genoa, Italy

[16] Ctr Riferimento Oncol Aviano CRO IRCCS, Clin & Expt Onco Hematol Unit, Aviano, Italy

[17] Azienda Osped Univ S Maria Misericordia, Ctr Trapianti & Terapie Cellulari, Clin Ematol, Udine, Italy

[18] Univ Trieste, Haematol, Trieste, Italy

[19] Azienda USL IRCCS Reggio Emilia, Hematol Unit, Reggio Emilia, Italy

[20] Azienda USL IRCCS Reggio Emilia, Sci Directorate, Reggio Emilia, Italy

[21] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 07期

基金：

瑞士国家科学基金会; 欧洲研究理事会;

关键词：

PROGRESSION; RISK;

D O I：

10.1002/ajh.26927

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E157 / E160

页数：4

共 50 条

[1] Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
Goebel, Maria
Eisele, Lewin
Moellmann, Michael
Huettmann, Andreas
Johansson, Patricia
Scholtysik, Rene
Bergmann, Manuela
Busch, Raymonde
Doehner, Hartmut
Hallek, Michael
Seiler, Till
Stilgenbauer, Stephan
Klein-Hitpass, Ludger
Duehrsen, Ulrich
Duerig, Jan
[J]. PLOS ONE, 2013, 8 (08):
[2] Progranulin plasma levels predict time to first treatment and overall survival in chronic lymphocytic leukemia
Goebel, M.
Eisele, L.
Huettmann, A.
Klein-Hitpass, L.
Duehrsen, U.
Duerig, J.
[J]. ONKOLOGIE, 2011, 34 : 196 - 196
[3] HYPOGAMMAGLOBULINEMIA IS A STRONG PREDICTOR OF TIME TO FIRST TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA
Reda, G.
Cassin, R.
Levati, G. V.
Fattizzo, B.
Mattiello, V.
Giannarelli, D.
Barcellini, W.
Cortelezzi, A.
[J]. HAEMATOLOGICA, 2017, 102 : 423 - 423
[4] Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia
Pineyroa, Juan A.
Magnano, Laura
Rivero, Andrea
Rivas-Delgado, Alfredo
Nadeu, Ferran
Correa, Juan Gonzalo
Gine, Eva
Villamor, Neus
Filella, Xavier
Colomer, Dolors
Lopez, Monica
Lopez-Oreja, Irene
Costa, Dolors
Aymerich, Marta
Bea, Silvia
Lopez-Guillermo, Armando
Campo, Elias
Delgado, Julio
Mozas, Pablo
[J]. HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 588 - 595
[5] Higher Mutational Burden Is an Independent Predictor of Shorter Time to First Treatment in Untreated Chronic Lymphocytic Leukemia Patients
Mikhaleva, Mariia
Tyekucheva, Svitlana
Mashima, Kiyomi
Fernandes, Stacey M.
Davids, Matthew S.
Brown, Jennifer R.
[J]. BLOOD, 2023, 142
[6] Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia
Maffei, Rossana
Martinelli, Silvia
Santachiara, Rita
Rossi, Davide
Guarnotta, Carla
Sozzi, Elisa
Zucchetto, Antonella
Rigolin, Gian Matteo
Fiorcari, Stefania
Castelli, Ilaria
Fontana, Marcella
Coluccio, Valeria
Leonardi, Giovanna
Zucchini, Patrizia
Tripodo, Claudio
Cuneo, Antonio
Gattei, Valter
Del Poeta, Giovanni
Forconi, Francesco
Gaidano, Gianluca
Torelli, Giuseppe
Marasca, Roberto
[J]. BLOOD, 2010, 116 (04) : 584 - 592
[7] Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
Rossi, Davide
Rasi, Silvia
Fabbri, Giulia
Spina, Valeria
Fangazio, Marco
Forconi, Francesco
Marasca, Roberto
Laurenti, Luca
Bruscaggin, Alessio
Cerri, Michaela
Monti, Sara
Cresta, Stefania
Fama, Rosella
De Paoli, Lorenzo
Bulian, Pietro
Gattei, Valter
Guarini, Anna
Deaglio, Silvia
Capello, Daniela
Rabadan, Raul
Pasqualucci, Laura
Dalla-Favera, Riccardo
Foa, Robin
Gaidano, Gianluca
[J]. BLOOD, 2012, 119 (02) : 521 - 529
[8] Mutations of NOTCH1 Are An Independent Predictor of Survival in Chronic Lymphocytic Leukemia
Rossi, Davide
Rasi, Silvia
Fabbri, Giulia
Spina, Valeria
Fangazio, Marco
Forconi, Francesco
Marasca, Roberto
Laurenti, Luca
Bruscaggin, Alessio
Cerri, Michaela
Monti, Sara
Cresta, Stefania
Fama, Rosella
De Paoli, Lorenzo
Bulian, Pietro
Gattei, Valter
Guarini, Anna
Deaglio, Silvia
Capello, Daniela
Rabadan, Raul
Pasqualucci, Laura
Dalla-Favera, Riccardo
Foa, Robin
Gaidano, Gianluca
[J]. BLOOD, 2011, 118 (21) : 131 - 131
[9] Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival
Oyekunle, Anthony A.
Durosinmi, Muheez A.
Bolarinwa, Ramoni A.
Owojuyigbe, Temilola
Salawu, Lateef
Akinola, Norah O.
[J]. CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS, 2016, 9 : 9 - 13
[10] CD49d is an independent prognostic marker for time to first treatment and overall survival in chronic lymphocytic leukaemia (CLL)
Majid, A.
Lin, T.
Best, G.
Hewamana, S.
Pratt, G.
Wagner, S.
Kennedy, D. B.
Miall, F.
Brennan, P.
Oscier, D. G.
Dyer, M. J. S.
Fegan, C.
Pepper, C.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 92 - 92

← 1 2 3 4 5 →